2006
DOI: 10.1186/1479-5876-4-55
|View full text |Cite
|
Sign up to set email alerts
|

Up-regulation of HLA class-I antigen expression and antigen-specific CTL response in cervical cancer cells by the demethylating agent hydralazine and the histone deacetylase inhibitor valproic acid

Abstract: Background: DNA hypermethylation and histone deacetylation are epigenetic events that contribute to the absence or downregulated expression of different components of the tumor recognition complex. These events affect the processing and presentation of antigenic peptides to CTLs by HLA class-I molecules. In this work evaluated the effect of the DNA hypomethylating agent hydralazine and the histone deacetylase inhibitor valproic acid, on the expression of HLA class-I molecules and on the antigen-specific immune… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
26
0
1

Year Published

2007
2007
2023
2023

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 59 publications
(29 citation statements)
references
References 42 publications
2
26
0
1
Order By: Relevance
“…Taken together, the high absolute levels of mRNAs encoding MHC-I components expressed in HPV+ head & neck and cervical carcinomas provide good evidence that high-risk HPV E7 is unable to efficiently block the IFN-γ induction of transcription of these genes in actual human tumors. Although this contrasts with the results of the studies listed above, our work agrees with other studies showing that various cervical cancer cell lines upregulate MHC-I in response to IFN-γ [ 59 , 60 , 61 ], and the treatment of HPV+ pre-cancerous cervical lesions in patients increased expression of at least HLA-B in a majority of cases [ 62 ]. It should be noted that the levels of MHC-I heavy chain mRNAs are statistically lower in HPV+ vs HPV− samples in the HNSC cohort ( Figure 1 ), despite the increased levels of IFN-γ ( Figure 7 ).…”
Section: Discussionsupporting
confidence: 76%
“…Taken together, the high absolute levels of mRNAs encoding MHC-I components expressed in HPV+ head & neck and cervical carcinomas provide good evidence that high-risk HPV E7 is unable to efficiently block the IFN-γ induction of transcription of these genes in actual human tumors. Although this contrasts with the results of the studies listed above, our work agrees with other studies showing that various cervical cancer cell lines upregulate MHC-I in response to IFN-γ [ 59 , 60 , 61 ], and the treatment of HPV+ pre-cancerous cervical lesions in patients increased expression of at least HLA-B in a majority of cases [ 62 ]. It should be noted that the levels of MHC-I heavy chain mRNAs are statistically lower in HPV+ vs HPV− samples in the HNSC cohort ( Figure 1 ), despite the increased levels of IFN-γ ( Figure 7 ).…”
Section: Discussionsupporting
confidence: 76%
“…Discovery of this methylation-mediated mechanism could have meaningful clinical implications, distinguishing patients whose tumors would be most responsive to immunotherapy. Additionally, elucidating patients with hypermethylated antigen processing genes might help identify those who would benefit from immunotherapy combined with adjuvant DNA hypomethylating agents or histone deacetylase inhibitors, as these agents were previously reported to recover HLA and TAP1/2 expression in cervical cancer cell lines, allowing them to be recognized by cytotoxic T cells (32, 33); both are currently in preclinical HGS EOC studies.…”
Section: Discussionmentioning
confidence: 99%
“…To analyze the suppressor capacity of Ado on effector CTL function, CD8+ T-cells specific for the YMLDLQPETT peptide derived from the E7 HPV-16 protein were obtained using a method previously reported by our group [41]. A total of 1 × 10 6 CTLs were previously cultured for 3 h in the presence of synthetic Ado (500 µM) or with 20 µl of supernatants obtained from MSCs cultured for 5 h in presence of 5 mM AMP.…”
Section: Methodsmentioning
confidence: 99%